Incidence of falls reduced following balance training in patients with osteoporosis

J Rehabil Med. 2018 Jul 17;50(7):577-581. doi: 10.2340/16501977-2334

Romosozumab versus placebo, alendronate, and teriparatide for postmenopausal osteoporosis

Climacteric. 2018 Apr;21(2):189-195

AAOS2018: Abaloparatide 80ug daily reduces rate of major NVFs in osteoporotic postmenopausal women

Zoledronic Acid, alendronate, and risedronate reduce vertebral, nonvertebral, and hip fracture

Osteoporos Int. 2016 Nov;27(11):3289-3300

Effects of teriparatide versus risedronate following pertrochanteric fracture fixation

J Bone Joint Surg Am. 2016 Nov 16;98(22):1868-1878

Lower incidence of vertebral fracture with romosozumab vs placebo for osteoporosis

N Engl J Med. 2016 Oct 20;375(16):1532-1543

Efficacy of vertebroplasty vs sham for acute vertebral fracture in patients over 60

Lancet. 2016 Oct 1;388(10052):1408-1416

The effect of eldecalcitol on balence and strength in women with osteoporosis

J Bone Miner Metab. 2016 Sep;34(5):547-54

Greater BMD increase with denosumab vs ZOL in patients switching from oral bisphosponates

J Clin Endocrinol Metab. 2016 Aug;101(8):3163-70

Combination therapy improves site-specific BMD vs. teriparatide & denosumab monotherapies

J Clin Densitom. 2016 Jul-Sep;19(3):346-51

Vertebral augmentation using SpineJack vs. balloon kyphoplasty for osteoporotic VCF

Osteoporos Int. 2016 Jun;27(6):2047-55

Immediate effects on bone metabolism biomarkers noted with resistance training and walking

BMC Musculoskelet Disord. 2016 Jun 8;17(1):254

Network meta-analysis of anti-osteoporosis therapies for oral glucocorticoid users

Osteoporos Int. 2016 Jun;27(6):1989-98

Percutaneous vertebroplasty vs. nonoperative treatment for osteoporotic vertebral fracture

J Bone Joint Surg Am. 2016 Jun 15;98(12):1041-51.

Efficacy of combined teriparatide & denosumab vs. single-drug treatment for osteoporosis

J Clin Endocrinol Metab. 2016 May;101(5):2023-30

WCO-IOF 2016: Alfacalcidol (Vit D analogue) vs. cholecalciferol (Vit D) for osteoporosis

Efficacy of zoledronic acid following PLIF in patients with osteoporosis

Osteoporos Int. 2016 Apr;27(4):1469-76

WCO-IOF 2016: Daily subcutaneous abaloparatide vs teriparatide & placebo for osteoporosis

WCO-IOF 2016: Greater BMD increase after 1 year of romosozumab vesus teripratide

WCO-IOF 2016: Denosumab versus zoledronic acid following oral bisphosphonate therapy